Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


POLARstar Optima Multimode Plate Reader with FP

Product Description
polarstar-optima.jpg

The POLARstar OPTIMA is a full multimode microplate reader which incorporates Simultaneous Dual Emission detection for fluorescent polarization. The POLARstar OPTIMA offers five different measurement principles:

• Fluorescence Polarization
• Fluorescence Intensity - including FRET
• Time-Resolved Fluorescence - including DELFIA®
• High-Performance Luminescence (flash and glow)- including BRET
• Absorbance - UV/Vis with path length correction

The POLARstar OPTIMA is designed for the widest possible range of non-radioactive labeled applications:

• Ca2+ Measurements (e.g. Ca2+Flux with Fura-2 or Indo-1)
• Molecular Interactions
• Enzyme Activity
• Cell Toxicity, Proliferation and Viability
• ATP Quantification
• Immunoassays
• Kinase, cAMP, and other second messenger signaling
• DNA/RNA quantification
• GFP and other fluorescent protein cell-based assays
• And many more…

The POLARstar OPTIMA is a multimode microplate reader that covers the wavelength range from 240 – 740 nm (900 nm optional). The POLARstar OPTIMA reads all plate formats from 6- up to 384-well. Top and bottom reading are standard, and the dual-channel detection system can be used for fluorescence polarization as well as dual emission wavelength measurements like FRET or BRET. Incubation up to 45°C or 60°C, gas vent connection, up to two built-in reagent injectors, fast filter wheels, and the ability to define up to 8 sets of filters are just some of the outstanding features found in the POLARstar OPTIMA.

Complete Software Package
The POLARstar OPTIMA comes with BMG LABTECH's established OPTIMA Reader Control Software and comprehensive MARS Data Analysis Software. The familiar and highly visual OPTIMA reader control software provides limitless possibilities for test set up and is fully compliant with FDA regulation 21 CFR Part 11. The well-organized Data Analysis Software – MARS – offers a Template Manager for building complex data processing protocols and a Wizard-guided interface to create easy step-by-step calculations, and much more.
Product POLARstar Optima Multimode Plate Reader with FP
Company BMG Labtech GmbH
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BMG Labtech GmbH
Allmendgruen 8, 77799 Ortenberg Germany

Tel: +49 781 96968-0
Fax: +49 781 96968-67
Email: hts@bmglabtech.com



Scientific News
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery
Scripps scientists have developed a method for rapidly identifying venoms.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
The Need for Speed
Evaluating MALDI-TOF as a high-throughput screening technology for the pharmaceutical industry.
Antarctic Sponge Extract Kills MRSA
New findings may provide opportunity for developing new drugs to fight dangerous bacteria currently highly resistant to treatment.
US-India Collab Finds Molecular Signatures of Severe Malaria
Study may be a significant advancement in understanding the causes of severe malaria.
Novel Way to Prevent Deadly Bacterial Infections
Monash scientists may have found a way to stop deadly bacteria from infecting patients. The discovery could lead to a whole new way of treating antibiotic-resistant “superbugs”
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Using Gene-editing Technology for Faster, Cheaper Antiviral Drug Development
UCLA scientists are working to develop special screening libraries based on a gene-editing technology called CRISPR.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!